Format
Sort by
Items per page

Send to

Choose Destination

Best matches for anticoagulation AND hemorrhage AND international normalized ratio AND warfarin:

Search results

Items: 1 to 20 of 721

1.

Fixed dose 4-factor prothrombin complex concentrate for the emergent reversal of warfarin: a retrospective analysis.

Astrup G, Sarangarm P, Burnett A.

J Thromb Thrombolysis. 2017 Nov 21. doi: 10.1007/s11239-017-1586-x. [Epub ahead of print]

PMID:
29164374
2.

Clinical manifestations and outcomes of severe warfarin overanticoagulation: from the EWA study.

Jaakkola S, Nuotio I, Kiviniemi TO, Virtanen R, Virta A, Airaksinen KEJ.

Ann Med. 2017 Nov 23:1-8. doi: 10.1080/07853890.2017.1407494. [Epub ahead of print]

PMID:
29156997
3.

Outcomes of Dabigatran and Warfarin for Atrial Fibrillation in Contemporary Practice: A Retrospective Cohort Study.

Go AS, Singer DE, Toh S, Cheetham TC, Reichman ME, Graham DJ, Southworth MR, Zhang R, Izem R, Goulding MR, Houstoun M, Mott K, Sung SH, Gagne JJ.

Ann Intern Med. 2017 Nov 14. doi: 10.7326/M16-1157. [Epub ahead of print]

PMID:
29132153
4.

Air Ambulance Delivery and Administration of Four-factor Prothrombin Complex Concentrate Is Feasible and Decreases Time to Anticoagulation Reversal.

Vines C, Tesseneer SJ, Cox RD, Darsey DA, Carbrey K, Puskarich MA.

Acad Emerg Med. 2017 Oct 27. doi: 10.1111/acem.13338. [Epub ahead of print]

PMID:
29077228
5.

Stent retriever thrombectomy combined with local thrombolytic therapy for cerebral venous sinus thrombosis: A case report.

Chen C, Wang Q, Li X, Lu Z, He J, Fang Q, Ke X, Duan C, Li T.

Exp Ther Med. 2017 Nov;14(5):3961-3970. doi: 10.3892/etm.2017.5043. Epub 2017 Aug 28.

6.

Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty: The GIFT Randomized Clinical Trial.

Gage BF, Bass AR, Lin H, Woller SC, Stevens SM, Al-Hammadi N, Li J, Rodríguez T Jr, Miller JP, McMillin GA, Pendleton RC, Jaffer AK, King CR, Whipple BD, Porche-Sorbet R, Napoli L, Merritt K, Thompson AM, Hyun G, Anderson JL, Hollomon W, Barrack RL, Nunley RM, Moskowitz G, Dávila-Román V, Eby CS.

JAMA. 2017 Sep 26;318(12):1115-1124. doi: 10.1001/jama.2017.11469.

PMID:
28973620
7.

Influence of Kidney Transplant Status on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage.

Yanik MV, Irvin MR, Beasley TM, Jacobson PA, Julian BA, Limdi NA.

Pharmacotherapy. 2017 Nov;37(11):1366-1373. doi: 10.1002/phar.2032. Epub 2017 Nov 2.

PMID:
28949423
8.

Predicting Major Bleeding in Ischemic Stroke Patients With Atrial Fibrillation.

Hilkens NA, Algra A, Greving JP.

Stroke. 2017 Nov;48(11):3142-3144. doi: 10.1161/STROKEAHA.117.019183. Epub 2017 Sep 20.

PMID:
28931618
9.

Rivaroxaban vs Warfarin Sodium in the Ultra-Early Period After Atrial Fibrillation-Related Mild Ischemic Stroke: A Randomized Clinical Trial.

Hong KS, Kwon SU, Lee SH, Lee JS, Kim YJ, Song TJ, Kim YD, Park MS, Kim EG, Cha JK, Sung SM, Yoon BW, Bang OY, Seo WK, Hwang YH, Ahn SH, Kang DW, Kang HG, Yu KH; Phase 2 Exploratory Clinical Study to Assess the Effects of Xarelto (Rivaroxaban) Versus Warfarin on Ischemia, Bleeding, and Hospital Stay in Acute Cerebral Infarction Patients With Non-valvular Atrial Fibrillation (Triple AXEL) Study Group.

JAMA Neurol. 2017 Oct 1;74(10):1206-1215. doi: 10.1001/jamaneurol.2017.2161.

PMID:
28892526
10.

Quality of anticoagulation control and hemorrhage risk among African American and European American warfarin users.

Limdi NA, Brown TM, Shendre A, Liu N, Hill CE, Beasley TM.

Pharmacogenet Genomics. 2017 Oct;27(10):347-355. doi: 10.1097/FPC.0000000000000298.

PMID:
28806200
11.

Assessment of the efficacy of a novel tailored vitamin K dosing regimen in lowering the International Normalised Ratio in over-anticoagulated patients: a randomised clinical trial.

Kampouraki E, Avery PJ, Wynne H, Biss T, Hanley J, Talks K, Kamali F.

Br J Haematol. 2017 Sep;178(5):800-809. doi: 10.1111/bjh.14777. Epub 2017 Aug 2.

PMID:
28771671
12.

D-dimer to guide the intensity of anticoagulation in Chinese patients after mechanical heart valve replacement: a randomized controlled trial.

Zhang L, Zheng X, Long Y, Wu M, Chen Y, Yang J, Liu Z, Zhang Z.

J Thromb Haemost. 2017 Oct;15(10):1934-1941. doi: 10.1111/jth.13782. Epub 2017 Sep 20.

PMID:
28762606
13.

Use of three procoagulants in improving bleeding outcomes in the warfarin patient with intracranial hemorrhage.

DeLoughery EP, DeLoughery TG.

Blood Coagul Fibrinolysis. 2017 Dec;28(8):612-616. doi: 10.1097/MBC.0000000000000645.

PMID:
28654426
14.

Efficacy and Safety of Uninterrupted Low-Intensity Warfarin for Radiofrequency Catheter Ablation of Atrial Fibrillation in the Elderly.

Xing Y, Xu B, Xu C, Peng F, Yang B, Qiu Y, Sun Y, Wang S, Guo H.

Ann Pharmacother. 2017 Sep;51(9):735-742. doi: 10.1177/1060028017712532. Epub 2017 Jun 2.

PMID:
28573932
15.

Thromboembolism and bleeding risk scores and predictors of cardiac death in a population with atrial fibrillation.

Silva RMFLD, Silva PAE, Lima MC, Sant'Anna LT, Silva TC, Moreira PHV, Gandra RM, Cavalcanti TR, Mourão PHV.

Arq Bras Cardiol. 2017 Jul;109(1):5-13. doi: 10.5935/abc.20170064. Epub 2017 May 25. English, Portuguese.

16.

Safety and Efficacy of Warfarin Therapy in Kawasaki Disease.

Baker AL, Vanderpluym C, Gauvreau KA, Fulton DR, de Ferranti SD, Friedman KG, Murray JM, Brown LD, Almond CS, Evans-Langhorst M, Newburger JW.

J Pediatr. 2017 Oct;189:61-65. doi: 10.1016/j.jpeds.2017.04.051. Epub 2017 May 25.

PMID:
28552449
17.

SAMe-TT2R2 Score in the Outpatient Anticoagulation Clinic to Predict Time in Therapeutic Range and Adverse Events.

Pivatto Junior F, Scheffel RS, Ries L, Wolkind RR, Marobin R, Barkan SS, Amon LC, Biolo A.

Arq Bras Cardiol. 2017 Apr;108(4):290-296. doi: 10.5935/abc.20170052. English, Portuguese.

18.

Genetic and Non-Genetic Factors Affecting the Quality of Anticoagulation Control and Vascular Events in Atrial Fibrillation.

Park YK, Lee MJ, Kim JH, Lee JS, Park RW, Kim GM, Chung CS, Lee KH, Kim JS, Lee SY, Bang OY.

J Stroke Cerebrovasc Dis. 2017 Jun;26(6):1383-1390. doi: 10.1016/j.jstrokecerebrovasdis.2017.02.022. Epub 2017 Apr 12.

PMID:
28412319
19.

Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy.

Lopes RD, Guimarães PO, Kolls BJ, Wojdyla DM, Bushnell CD, Hanna M, Easton JD, Thomas L, Wallentin L, Al-Khatib SM, Held C, Gabriel Melo de Barros E Silva P, Alexander JH, Granger CB, Diener HC.

Blood. 2017 Jun 1;129(22):2980-2987. doi: 10.1182/blood-2016-08-731638. Epub 2017 Mar 29.

PMID:
28356246
20.

Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation.

Calkins H, Willems S, Gerstenfeld EP, Verma A, Schilling R, Hohnloser SH, Okumura K, Serota H, Nordaby M, Guiver K, Biss B, Brouwer MA, Grimaldi M; RE-CIRCUIT Investigators.

N Engl J Med. 2017 Apr 27;376(17):1627-1636. doi: 10.1056/NEJMoa1701005. Epub 2017 Mar 19.

Supplemental Content

Loading ...
Support Center